Cancer Genetics Pharmacotyping Links Childhood Leukemia Subtypes to Treatment Response With drug sensitivity and genomic profiles on acute lymphoblastic leukemia cells, coupled with patient data, researchers saw pharmacotypes related to treatment response and outcomes. Sophia Genetics Files for $100M IPO, Inks Cancer Data Deal With GE Healthcare Sophia, which will trade on the Nasdaq, seeks to raise $100 million in an IPO, and separately announced a partnership with GE Healthcare. Geisinger Health System Wins $3.6M NIH Grant to Study Genetics of Cancer Risk The health system will partner with the NCI to look for new cancer risk variants in a large population biobank, in the hopes of improving screening and care. Cancer Genetics to Sell $17.5M in Common Stock Through Direct Offering The New Jersey-based cancer drug-discovery services provider said it had signed agreements to sell the shares to unnamed institutional investors. Cancer Genetics to Raise $10M in Private Placement The firm plans to use the net proceeds for general corporate purposes, including working capital and capital expenditures. Nov 13, 2020 Cancer Genetics Q3 Revenues Down 24 Percent Aug 24, 2020 Cancer Genetics to Acquire Organoid Startup Stemonix Aug 14, 2020 Cancer Genetics Q2 Revenues Drop 5 Percent Jun 25, 2020 Cancer Genetics Q1 Revenues Drop 22 Percent Jun 1, 2020 Cancer Genetics Q4 2019 Revenues Up 12 Percent Nov 20, 2019 Cancer Genetics' Discovery Services Drive Q3 Revenue Gains Nov 13, 2019 Interpace Diagnostics Reports 33 Percent Q3 Revenue Growth; Changes Name to Interpace Biosciences Oct 25, 2019 Cancer Genetics Settles Failed Merger Deal With NovellusDx; Receives $6M From Interpace Oct 24, 2019 Cancer Genetics Announces 1-for-30 Reverse Stock Split Aug 20, 2019 Cancer Genetics Posts 15 Percent Rise in Q2 Revenues Jul 16, 2019 Parkinson's Foundation, Fulgent Genetics Partner on Genetic Testing Initiative Jul 15, 2019 Interpace Dx Acquires Cancer Genetics' Biopharma Services May 21, 2019 Cancer Genetics Q1 Revenues Fall 11 Percent Apr 16, 2019 Cancer Genetics Q4 Revenues Down 9 Percent Jan 11, 2019 People in the News: Cindy Perettie, William Finger, Richard Compton, More Jan 10, 2019 Cancer Genetics Targets $3M in Public Offering Dec 17, 2018 Cancer Genetics Cancels Planned Merger With NovellusDx Nov 20, 2018 Cancer Genetics Q3 Revenues Fall 26 Percent Nov 16, 2018 People in the News: Glenn Miles, Roy Smythe, Steve Ziganti, More Oct 18, 2018 Cancer Genetics, GeneCast Ink Cancer Test Distribution Deal Load More Breaking News Cancer Prognoses Informed by Module-Based Approach, Study Finds People in the News at Illumina, Centogene, BioSkryb New Products Posted to GenomeWeb: Bio-Rad, BD, Analytik Jena, BioMérieux Genetic Technologies to Raise A$5M in Direct Stock Offering In Brief This Week: SD Biosensors, Meridian, Oncocyte, Opko Health, GeneDx, More The Scan Study Reveals New Details About Genetics of Major Cause of Female Infertility Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency. Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis. Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven. White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.